tiprankstipranks

Laura Clague Insider Profile

4 Followers
Laura Clague, CFO at Travere Therapeutics, holds 104.79K shares in Standard BioTools (Ticker: LAB), holds 35.66K shares in Travere Therapeutics (Ticker: TVTX), holds 286.31K shares in Genasys (Ticker: GNSS).
tipranks
Laura Clague

Laura Clague
Travere Therapeutics (TVTX)
CFO

Ranked #68,057 out of 98,564 Corporate Insiders

Profitable Transactions

20%
1 out of 5 Profitable Transactions

Average Return

-10.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$1M
55.04%
25.21%
19.75%
0.00%
A breakdown of Laura Clague's holdings

Insider Roles

Genasys
(GNSS)
Director
Standard BioTools
(LAB)
Director
Travere Therapeutics
(TVTX)
CFO
Turtle Beach
(HEAR)
Director
Roles that Laura Clague holds in companies

Most Profitable Insider Trade

Stock:
Genasys
(GNSS)
Rating:Informative Buy
Date:Feb 24, 2022 - Feb 24, 2023
Return:+8.60%
The most profitable trade made by Laura Clague

Laura Clague's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Travere Therapeutics
May 12, 2022
CFO
Uninformative Sell
47.32K
$208.58K
Standard BioTools
Jun 16, 2023
Director
Uninformative Buy
$266.17K
Genasys
Apr 27, 2022
Director
Informative Buy
66.50K
$581.21K
Turtle Beach
Director
$0.00
List of latest transactions for each holding click on a transaction to see Laura Clague's performance on stock

Laura Clague insider profile FAQ

What is the percentage of profitable transactions made by Laura Clague?
The percentage of profitable transactions made by Laura Clague is 20%.
    What is the average return per transaction made by Laura Clague?
    The average return per transaction made by Laura Clague is -10.70%.
      What stocks does Laura Clague hold?
      Laura Clague holds: TVTX, LAB, GNSS, HEAR stocks.
        What was Laura Clague’s latest transaction?
        Laura Clague latest transaction was an Uninformative Buy of ―.
          What was Laura Clague's most profitable transaction?
          Laura Clague’s most profitable transaction was an Informative Buy of GNSS stock on February 24, 2022. The return on the trade was 8.60%.
            What is Laura Clague's role in Travere Therapeutics?
            Laura Clague's role in Travere Therapeutics is CFO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.